Myelodysplastic syndromes: from conductiong clinical trials of novel therapies to evaluating real-life effectiveness of exisiting therapies
Zeidan A. Myelodysplastic syndromes: from conductiong clinical trials of novel therapies to evaluating real-life effectiveness of exisiting therapies. International Journal Of Hematologic Oncology 2015, 4: 215-217. DOI: 10.2217/ijh.15.25.Peer-Reviewed Original ResearchMyelodysplastic syndromeHematologic malignanciesNovel therapiesYale Cancer CenterReal-life effectivenessMyeloid hematologic malignanciesHematology/oncology fellowshipRochester General HospitalInternal medicine residencyCancer CenterClinical trialsGeneral HospitalClinical investigationFaculty of MedicineOncology fellowshipsMalignancyTherapyClinical interestTranslational researchMedicine residencyOutcomes researchMBBS degreeMedicineJohns Hopkins UniversityResearch Fellowship